 SOUTH SAN FRANCISCO, Calif., Jan. 04, 2023 GLOBE NEWSWIRE -- Surrozen, Inc. Surrozen or the Company Nasdaq: SRZN, a company pioneering targeted therapeutics that selectively activate the Wnt pathway for tissue repair and regeneration, will present on January 12, 2023 at 7:30 a.m. Pacific time at the 41st Annual J.P. Morgan Healthcare Conference. 